The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
Open accessAbstract
Increasing survival of motor neuron 2, centromeric(SMN2) exon 7 inclusion to express more full-length SMN protein in motor neurons is a promising approach to treat spinal muscular atrophy (SMA), a genetic neurodegenerative disease. Previously, we identified a potent 2′-O-(2-methoxyethyl) (MOE) phosphorothioate-modified antisense oligonucleotide (ASO) that blocks an SMN2 intronic splicing silencer element and efficiently promotes exon 7 inclusion in transgenic mouse peripheral tissues after systemic administration. Here we address its efficacy in the spinal cord—a prerequisite for disease treatment—and its ability to rescue a mild SMA mouse model that develops tail and ear necrosis, resembling the distal tissue necrosis reported in some SMA infants. Using a micro-osmotic pump, we directly infused the ASO into a lateral cerebral ventricle in adult mice expressing a human SMN2 transgene; the ASO gave a robust and long-lasting increase in SMN2 exon 7 inclusion measured at both the mRNA and protein levels in spinal cord motor neurons. A single embryonic or neonatal intracerebroventricular ASO injection strikingly rescued the tail and ear necrosis in SMA mice. We conclude that this MOE ASO is a promising drug candidate for SMA therapy, and, more generally, that ASOs can be used to efficiently redirect alternative splicing of target genes in the CNS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Foust, K. D., Wang, X., McGovern, V. L., Braun, L., Bevan, A. K., Haidet, A. M., Le, T. T., Morales, P. R., Rich, M. M., Burghes, A. H. M., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1610 · Cited by 688
RetractedIdentification and characterization of a spinal muscular atrophy-determining gene
Lefebvre, S., Bürglen, L., Reboullet, S., Clermont, O., Burlet, P., Viollet, L., Benichou, B., Cruaud, C., Millasseau, P., Zeviani, M., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90460-3 · Cited by 3,990
Mechanisms underlying inflammation in neurodegeneration
Glass, C. K., Saijo, K., Winner, B., Marchetto, M. C., & Gage, F. H. (2010) · Cell · doi:10.1016/j.cell.2010.02.016 · Cited by 3,580
Transvascular delivery of small interfering RNA to the central nervous system
Kumar, P., Wu, H., McBride, J. L., Jung, K.-E., Hee Kim, M., Davidson, B. L., Kyung Lee, S., Shankar, P., & Manjunath, N. (2007) · Nature · doi:10.1038/nature05901 · Cited by 1,246
Correlation between severity and SMN protein level in spinal muscular atrophy
Lefebvre, S., Burlet, P., Liu, Q., Bertrandy, S., Clermont, O., Munnich, A., Dreyfuss, G., & Melki, J. (1997) · Nature Genetics · doi:10.1038/ng0797-265 · Cited by 1,100
Lunn, M. R., & Wang, C. H. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60921-6 · Cited by 995
Consensus Statement for Standard of Care in Spinal Muscular Atrophy
Wang, C. H., Finkel, R. S., Bertini, E. S., Schroth, M., Simonds, A., Wong, B., Aloysius, A., Morrison, L., Main, M., Crawford, T. O., et al. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305788 · Cited by 961
A novel nuclear structure containing the survival of motor neurons protein.
Liu, Q., & Dreyfuss, G. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00725.x · Cited by 780
Monani, U. R. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.3.333 · Cited by 729
The survival motor neuron protein in spinal muscular atrophy
Coovert, D. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.8.1205 · Cited by 714
A mouse model for spinal muscular atrophy
Hsieh-Li, H. M., Chang, J.-G., Jong, Y.-J., Wu, M.-H., Wang, N. M., Tsai, C. H., & Li, H. (2000) · Nature Genetics · doi:10.1038/71709 · Cited by 702
International SMA Consortium Meeting (26–28 June 1992, Bonn, Germany)
Munsat, T. L., & Davies, K. E. (1992) · Neuromuscular Disorders · doi:10.1016/s0960-8966(06)80015-5 · Cited by 666
Schrank, B., Götz, R., Gunnersen, J. M., Ure, J. M., Toyka, K. V., Smith, A. G., & Sendtner, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9920 · Cited by 661
Le, T. T., Pham, L. T., Butchbach, M. E. R., Zhang, H. L., Monani, U. R., Coovert, D. D., Gavrilina, T. O., Xing, L., Bassell, G. J., & Burghes, A. H. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi078 · Cited by 598
Hua, Y., Vickers, T. A., Okunola, H. L., Bennett, C. F., & Krainer, A. R. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.01.014 · Cited by 574
Self-citationEssential Role for the SMN Complex in the Specificity of snRNP Assembly
Pellizzoni, L., Yong, J., & Dreyfuss, G. (2002) · Science · doi:10.1126/science.1074962 · Cited by 545
Antisense oligonucleotide therapy for neurodegenerative disease
Smith, R. A. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25424 · Cited by 506
Singh, N. K., Singh, N. N., Androphy, E. J., & Singh, R. N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.4.1333-1346.2006 · Cited by 454
McWhorter, M. L., Monani, U. R., Burghes, A. H. M., & Beattie, C. E. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200303168 · Cited by 423
Nanogels for Oligonucleotide Delivery to the Brain
Vinogradov, S. V., Batrakova, E. V., & Kabanov, A. V. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034164r · Cited by 377
In vivo electroporation in the embryonic mouse central nervous system
Saito, T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.276 · Cited by 376
Baker, B. F., Lot, S. S., Condon, T. P., Cheng-Flournoy, S., Lesnik, E. A., Sasmor, H. M., & Bennett, C. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11994 · Cited by 371
Self-citationControl of alternative splicing through siRNA-mediated transcriptional gene silencing
Alló, M., Buggiano, V., Fededa, J. P., Petrillo, E., Schor, I., de la Mata, M., Agirre, E., Plass, M., Eyras, E., Elela, S. A., et al. (2009) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1620 · Cited by 340
Enhancement of SMN2 Exon 7 Inclusion by Antisense Oligonucleotides Targeting the Exon
Hua, Y., Vickers, T. A., Baker, B. F., Bennett, C. F., & Krainer, A. R. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050073 · Cited by 340
Self-citationGabanella, F., Butchbach, M. E. R., Saieva, L., Carissimi, C., Burghes, A. H. M., & Pellizzoni, L. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000921 · Cited by 315
A multiprotein complex mediates the ATP-dependent assembly of spliceosomal U snRNPs
Meister, G., Bühler, D., Pillai, R., Lottspeich, F., & Fischer, U. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-945 · Cited by 307
Correction of disease-associated exon skipping by synthetic exon-specific activators
Cartegni, L., & Krainer, A. R. (2003) · Nature Structural Biology · doi:10.1038/nsb887 · Cited by 301
Self-citationPassini, M. A., Bu, J., Roskelley, E. M., Richards, A. M., Sardi, S. P., O’Riordan, C. R., Klinger, K. W., Shihabuddin, L. S., & Cheng, S. H. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41615 · Cited by 292
Self-citationSkordis, L. A., Dunckley, M. G., Yue, B., Eperon, I. C., & Muntoni, F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0633863100 · Cited by 274
Spinal Muscular Atrophy: Clinical Classification and Disease Heterogeneity
Russman, B. S. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305673 · Cited by 262
International SMA consortium meeting
Munsat, T. L. (1992) · Medical Entomology and Zoology · Cited by 243
SAHA ameliorates the SMA phenotype in two mouse models for spinal muscular atrophy
Riessland, M., Ackermann, B., Förster, A., Jakubik, M., Hauke, J., Garbes, L., Fritzsche, I., Mende, Y., Blumcke, I., Hahnen, E., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq023 · Cited by 220
Gavrilina, T. O., McGovern, V. L., Workman, E., Crawford, T. O., Gogliotti, R. G., DiDonato, C. J., Monani, U. R., Morris, G. E., & Burghes, A. H. M. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddm379 · Cited by 212
Zhang, H., Xing, L., Rossoll, W., Wichterle, H., Singer, R. H., & Bassell, G. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3967-05.2006 · Cited by 200
Whitesell, L., Geselowitz, D., Chavany, C., Fahmy, B., Walbridge, S., Alger, J. R., & Neckers, L. M. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.10.4665 · Cited by 183
Molecular Functions of the SMN Complex
Kolb, S. J., Battle, D. J., & Dreyfuss, G. (2007) · Journal of Child Neurology · doi:10.1177/0883073807305666 · Cited by 171
Geary, R. S., Yu, R. Z., Watanabe, T., Henry, S. P., Hardee, G. E., Chappell, A., Matson, J., Sasmor, H., Cummins, L., & Levin, A. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1419 · Cited by 162
Sustained improvement of spinal muscular atrophy mice treated with trichostatin a plus nutrition
Narver, H. L., Kong, L., Burnett, B. G., Choe, D. W., Bosch‐Marcé, M., Taye, A. A., Eckhaus, M., & Sumner, C. J. (2008) · Annals of Neurology · doi:10.1002/ana.21449 · Cited by 160
Lim, S. R., & Hertel, K. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107632200 · Cited by 159
Cellular distribution of phosphorothioate oligodeoxynucleotides in normal rodent tissues.
Butler, M., Stecker, K., & Bennett, C. F. (1997) · PubMed · Cited by 151
Self-citationWilliams, J. H., Schray, R. C., Patterson, C. A., Ayitey, S., Tallent, M. K., & Lutz, G. J. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0950-09.2009 · Cited by 142
Vascular Perfusion Abnormalities in Infants with Spinal Muscular Atrophy
Araújo, A. P. D. Q. C., Araújo, M. L. C., & Swoboda, K. J. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.01.071 · Cited by 140
Crooke, S. T. (2004) · Current Molecular Medicine · doi:10.2174/1566524043360375 · Cited by 139
Yang, Z. F., Ho, D. W., Lau, C. K., Lam, C. T., Lum, C. T., Poon, R. T. P., & Fan, S. T. (2005) · International Immunology · doi:10.1093/intimm/dxh316 · Cited by 138
Binding and Cleavage Specificities of Human Argonaute2
Lima, W. F., Wu, H., Nichols, J. G., Sun, H., Murray, H. M., & Crooke, S. T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010835 · Cited by 136
Baughan, T. D., Dickson, A. L., Osman, E. Y., & Lorson, C. L. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp076 · Cited by 124
Multiple therapeutic effects of valproic acid in spinal muscular atrophy model mice
Tsai, L., Tsai, M., Ting, C.-H., & Li, H. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0388-1 · Cited by 117
Identification of a Cis-acting Element for the Regulation ofSMN Exon 7 Splicing
Miyajima, H., Miyaso, H., Okumura, M., Kurisu, J., & Imaizumi, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200851200 · Cited by 104
Belverud, S. A., Mogilner, A. Y., & Schulder, M. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2007.10.070 · Cited by 98
Trans-Splicing-Mediated Improvement in a Severe Mouse Model of Spinal Muscular Atrophy
Coady, T. H., & Lorson, C. L. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4489-09.2010 · Cited by 94
Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
Meyer, K., Marquis, J., TRUEB, J., Nlend, R. N., Verp, S., Ruepp, M., Imboden, H., Barde, I., Trono, D., & Schümperli, D. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn382 · Cited by 94
Correction of SMN2 Pre-mRNA splicing by antisense U7 small nuclear RNAs
Madocsai, C., Lim, S. R., Geib, T., Lam, B. J., & Hertel, K. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.08.022 · Cited by 92
Restoration of SMN Function: Delivery of a Trans-splicing RNA Re-directs SMN2 Pre-mRNA Splicing
Coady, T. H., Shababi, M., Tullis, G. E., & Lorson, C. L. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300222 · Cited by 90
Butler, M., Crooke, R. M., Graham, M. J., Lemonidis, K. M., Lougheed, M., Murray, S. F., Witchell, D. R., Steinbrecher, U. P., & Bennett, C. F. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35317-0 · Cited by 72
Self-citationEstablishing a standardized therapeutic testing protocol for spinal muscular atrophy
Tsai, L., Tsai, M., Lin, T.-B., Hwu, W., & Li, H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.07.004 · Cited by 69
Geib, T., & Hertel, K. J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008204 · Cited by 50
Cited by
Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy
Mendell, J. R., Al-Zaidy, S., Shell, R., Arnold, W. D., Rodino-Klapac, L. R., Prior, T. W., Lowes, L., Alfano, L., Berry, K., Church, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1706198 · Cited by 2,381
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
Finkel, R. S., Mercuri, E., Darras, B. T., Connolly, A. M., Kuntz, N. L., Kirschner, J., Chiriboga, C. A., Saito, K., Servais, L., Tizzano, E., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1702752 · Cited by 2,337
Self-citationNusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
Mercuri, E., Darras, B. T., Chiriboga, C. A., Day, J. W., Campbell, C., Connolly, A. M., Iannaccone, S. T., Kirschner, J., Kuntz, N. L., Saito, K., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1710504 · Cited by 1,433
Self-citationThe human splicing code reveals new insights into the genetic determinants of disease
Xiong, H. Y., Alipanahi, B., Lee, L. J., Bretschneider, H., Merico, D., Yuen, R. K. C., Hua, Y., Gueroussov, S., Najafabadi, H. S., Hughes, T. R., et al. (2015) · Science · doi:10.1126/science.1254806 · Cited by 1,220
Self-citationRNA therapeutics: beyond RNA interference and antisense oligonucleotides
Kole, R., Krainer, A. R., & Altman, S. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3625 · Cited by 1,152
Self-citation
Metadata
- Authors
- Hua, Y., Sahashi, K., Hung, G., Rigo, F., Passini, M. A., Bennett, C. F., & Krainer, A. R.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2010-07-12
- Volume
- 24
- Issue
- 15
- Pages
- 1634-1644
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2136930242
- Cited by
- 664
- References
- 56
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.